Stock Earnings

Question 1

What are Biotest AG's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Biotest AG has a total asset of $1,434, Net profit of $26

Question 2

What are the key financial ratios for BIESF?

Accepted Answer

Biotest AG's Current ratio is 1.58, has a Net margin is 3.58, sales per share of $18.34.

Question 3

How is Biotest AG's revenue broken down by segment or geography?

Accepted Answer

Biotest AG largest revenue segment is European Union, at a revenue of 260,399,999 in the most earnings release.For geography, Rest of the World is the primary market for Biotest AG, at a revenue of 234,100,000.

Question 4

Is Biotest AG profitable?

Accepted Answer

yes, according to the latest financial statements, Biotest AG has a net profit of $26

Question 5

Does Biotest AG have any liabilities?

Accepted Answer

yes, Biotest AG has liability of 903

Question 6

How many outstanding shares for Biotest AG?

Accepted Answer

Biotest AG has a total outstanding shares of 39.57

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	635	726	684	516	515	484
Revenue Growth (YoY)	-16%	6%	33%	0%	6%	16%
Cost of Revenue	487	502	404	391	434	354
Gross Profit	147	223	280	124	80	130
Selling, General & Admin	85	79	73	72	72	69
Research & Development	56	56	66	49	51	55
Operating Expenses	135	137	160	141	130	132
Other Non Operating Income (Expenses)	--	-2	-2	-5	-3	-3
Pretax Income	-25	46	106	-30	-62	-30
Income Tax Expense	-1	20	-20	0	0	1
Net Income	-24	26	127	-32	-64	-32
Net Income Growth	-115.99%	-80%	-497%	-50%	100%	700%
Shares Outstanding (Diluted)	38.9	39.57	39.57	39.57	39.57	39.57
Shares Change (YoY)	-2%	0%	0%	0%	0%	0%
EPS (Diluted)	-0.62	0.67	3.21	-0.82	-1.64	-0.81
EPS Growth	-115.99%	-79%	-491%	-50%	102%	575%
Free Cash Flow	14	32	-36	-69	15	-43
Free Cash Flow Per Share	0.35	0.8	-0.9	-1.74	0.37	-1.08
Gross Margin	23.14%	30.71%	40.93%	24.03%	15.53%	26.85%
Operating Margin	1.73%	11.84%	17.54%	-3.1%	-9.7%	-0.41%
Profit Margin	-3.77%	3.58%	18.56%	-6.2%	-12.42%	-6.61%
Free Cash Flow Margin	2.2%	4.4%	-5.26%	-13.37%	2.91%	-8.88%
EBITDA	--	126	155	19	-19	27
EBITDA Margin	--	17.35%	22.66%	3.68%	-3.68%	5.57%
D&A For EBITDA	--	40	35	35	31	29
EBIT	11	86	120	-16	-50	-2
EBIT Margin	1.73%	11.84%	17.54%	-3.1%	-9.7%	-0.41%
Effective Tax Rate	4%	43.47%	-18.86%	0%	0%	-3.33%

Biotest AG (BIESF) Price

BIESF Stock Price Chart

BIESF Income

Follow-Up Questions